ResearcherThe Seventh Affiliated Hospital of Sun Yat-sen UniversityActive in the last 2 years

Yuxin Lin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-5519-8562; OpenAlex author ID A5108527831. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2026: 1 paper

Papers 1

NKG2A-HLA-E and TIM3-galectin 9 pathways promote immune inhibition and represent therapeutic vulnerabilities in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00262-026-04479-9 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Junzong Chen · 1 shared paper, 2026 · strength 0.23
- Paper NKG2A-HLA-E and TIM3-galectin 9 pathways promote immune inhibition and represent therapeutic vulnerabilities in pancrea… DOI 10.1007/s00262-026-04479-9 ↗
Youwen Fan · 1 shared paper, 2026 · strength 0.23
- Paper NKG2A-HLA-E and TIM3-galectin 9 pathways promote immune inhibition and represent therapeutic vulnerabilities in pancrea… DOI 10.1007/s00262-026-04479-9 ↗
Guoying Zhou · 1 shared paper, 2026 · strength 0.23
- Paper NKG2A-HLA-E and TIM3-galectin 9 pathways promote immune inhibition and represent therapeutic vulnerabilities in pancrea… DOI 10.1007/s00262-026-04479-9 ↗
Linxiang Lan · 1 shared paper, 2026 · strength 0.23
- Paper NKG2A-HLA-E and TIM3-galectin 9 pathways promote immune inhibition and represent therapeutic vulnerabilities in pancrea… DOI 10.1007/s00262-026-04479-9 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.